Bay City Capital
Finance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Battery St Ste 400, San Francisco, C...Phone Number
(415) 676-3830Website
www.baycitycapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
2
1
1
About Bay City Capital
Bay City Capital is a venture capital firm founded in 1997 that specializes in investing in life sciences. With five venture capital funds and $1.3 billion in capital commitments, the firm has invested in over 100 companies worldwide. Their portfolio includes companies that have achieved significant milestones, such as FDA approvals and therapeutic advancements. Bay City Capital aims to support innovative companies in the life sciences sector.Explore more
Bay City Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bay City Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Bay City Capital launches new products
Congratulate Masked Content for being promoted to Masked Content at Bay City Capital
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Bay City Capital recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Bay City Capital has new funding data
Click to see if Bay City Capital had a recent Job posting/layoffs
Check out if Bay City Capital is spiking on competitors!
Check if Bay City Capital has recently received funding, and reach out quickly before it becomes old news!
Bay City Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Bay City Capital
Find 2 more new buyers
Compare Similar Companies to Bay City Capital
Compare insights from companies similar to Bay City Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
1994
VH
Victor HebertManaging Director, Chief Admisitrative Officer and Chief Legal Officer
Company Profile Activity
Activity Insights
Bay City Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Bay City Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Bay City Capital.
Bay City Capital Tech Stack
A closer look at the technologies used by Bay City Capital
Bay City Capital News & Media
Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development
NEW YORK, March 14, 2018 /PRNewswire/ -- Bridge Medicines and the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) announced today the acceptance into Bridge Medicines of its first drug candidate, a small molecule for the treatment of basal cell carcinoma, that originated in...Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
LAUSANNE, Switzerland, January 4, 2018 /PRNewswire/ -- Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully closed a Series B financing...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bay City Capital
Sign Up For FreeTo access detailed company insights
Bay City Capital is a venture capital firm founded in 1997 that specializes in investing in life sciences. With five venture capital funds and $1.3 billion in capital commitments, the firm has invested in over 100 companies worldwide. Their portfolio includes companies that have achieved significant milestones, such as FDA approvals and therapeutic... Read More
